Publicaciones en colaboración con investigadores/as de Universidad de Sevilla (59)

2024

  1. A Cross-Sectional Study to Assess the Knowledge of Pharmacy Students About Drug Pollution in Spain

    American Journal of Pharmaceutical Education, Vol. 88, Núm. 9

  2. Coumarin-azasugar-benzyl conjugates as non-neurotoxic dual inhibitors of butyrylcholinesterase and cancer cell growth

    Organic & biomolecular chemistry, Vol. 22, Núm. 17, pp. 3425-3438

  3. Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases

    Bioorganic Chemistry, Vol. 145

  4. Novel Coumarin-Steroid/Terpenoid Hybrids: In Vitro and In Silico Anticancer Studies

    Chemistry and Biodiversity

  5. Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy

    Hepatology (Baltimore, Md.), Vol. 80, Núm. 4, pp. 791-806

  6. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Biotinylated selenocyanates: Potent and selective cytostatic agents

    Bioorganic Chemistry, Vol. 133

  3. Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors

    International Journal of Molecular Sciences, Vol. 24, Núm. 11

  4. Fluoro-labelled sp2-iminoglycolipids with immunomodulatory properties

    European Journal of Medicinal Chemistry, Vol. 255

  5. Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 38, Núm. 1, pp. 349-360

  6. N-Substituted 3-Aminooxindoles and N-Propargyl Derivatives: Potential Biological Activities against Alzheimer's Disease

    Results in Chemistry, Vol. 6

  7. Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19

    Translational Psychiatry, Vol. 13, Núm. 1

  8. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

2022

  1. 2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 37, Núm. 1, pp. 168-177

  2. A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE)

    Journal of enzyme inhibition and medicinal chemistry, Vol. 37, Núm. 1, pp. 2395-2402

  3. Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease

    Bioorganic Chemistry, Vol. 127

  4. Chemoselective Preparation of New Families of Phenolic-Organoselenium Hybrids—A Biological Assessment

    Molecules, Vol. 27, Núm. 4

  5. Iridium-and Palladium-Based Catalysts in the Pharmaceutical Industry

    Catalysts, Vol. 12, Núm. 2

  6. Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes

    Gut, Vol. 71, Núm. 10, pp. 2138-2140